for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Davita Inc

DVA.N

Latest Trade

59.21USD

Change

0.55(+0.94%)

Volume

368,114

Today's Range

58.42

 - 

59.71

52 Week Range

43.40

 - 

79.02

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
58.66
Open
58.42
Volume
368,114
3M AVG Volume
64.75
Today's High
59.71
Today's Low
58.42
52 Week High
79.02
52 Week Low
43.40
Shares Out (MIL)
160.30
Market Cap (MIL)
9,408.01
Forward P/E
12.41
Dividend (Yield %)
--

Next Event

Q3 2019 DaVita Inc Earnings Release

Latest Developments

More

Berkshire Hathaway Inc Reports 27.8% Stake In Davita Inc

FTC Approves Final Order Imposing Conditions On UnitedHealth Group's Proposed Acquisition Of Davita Medical Group

Davita Announces New Senior Secured Credit Agreement

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Davita Inc

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Industry

Healthcare Facilities

Contact Info

2000 16th St

+1.310.5362668

https://www.davita.com/

Executive Leadership

Kent J. Thiry

Executive Chairman of the Board

Javier J. Rodriguez

Chief Executive Officer, Director

Joel Ackerman

Chief Financial Officer, Treasurer

James K. Hilger

Chief Accounting Officer

James O. Hearty

Chief Compliance Officer

Key Stats

2.42 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

14.7K

2017

15.6K

2018

11.4K

2019(E)

11.3K
EPS (USD)

2016

3.850

2017

3.320

2018

3.570

2019(E)

4.730
Price To Earnings (TTM)
17.85
Price To Sales (TTM)
0.84
Price To Book (MRQ)
2.38
Price To Cash Flow (TTM)
7.07
Total Debt To Equity (MRQ)
221.50
LT Debt To Equity (MRQ)
132.81
Return on Investment (TTM)
5.56
Return on Equity (TTM)
3.71

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up